FIRE: Focused Initial Rapid Evaluation
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.
Boxes in the red color signify that an urgent management is needed.
| D03=
Low risk
Initial conservative strategy
| | | Identify cardinal findings of unstable angina/ NSTEMI :
❑ Chest pain or chest discomfort
- ❑ Sudden onset
- ❑ Sensation of heaviness, tightness, pressure, or squeezing
- ❑ Duration> 20 minutes (but usually less than half an hour)
- ❑ Radiation to the left arm, jaw, neck, right arm, back or epigastrium
- ❑ No relief with medications
- ❑ No relief with rest
- ❑ Worse with time
- ❑ Worse with exertion
- ❑ Associated symptoms of palpitations, nausea, vomiting, sweating, dyspnea, and
lightheadedness
❑ Characteristic ECG changes consistent with unstable angina/ NSTEMI
- ❑ No changes
- ❑ Non specific ST / T wave changes
- ❑ Flipped or inverted T waves
- ❑ ST depression (carries the poorest prognosis)
❑ Increase in >99th percentile of upper limit of normal of troponin and / or CK MB , which is consistent with NSTEMI | |
| | | | | | | | |
| | | Rule out life threatening alternative diagnoses:
❑ Aortic dissection (suggestive findings: back pain, interscapular pain, aortic regurgitation, pulsus paradoxus, blood pressure discrepancy between the arms)
❑ Pulmonary embolism (suggestive findings: acute onset of dyspnea, tachypnea, hemoptysis, previous DVT)
❑ Cardiac tamponade (suggestive findings: hypotension, jugular venous distention, muffled heart sounds, pulsus paradoxus)
❑ Tension pneumothorax (suggestive findings: sudden dyspnea, tachycardia, chest trauma, unilateral absence of breath sound)
❑ Esophageal rupture (suggestive findings: vomiting, subcutaneous emphysema) |
| | | | | | | | |
| | | Begin initial treatment: ❑ Administer aspirin
- ❑ 162 to 325 mg of non enteric aspirin,orally, crushed or chewed, THEN
- ❑ 75 to 325 mg/day
❑ Administer 2-4 L/min oxygen via nasal cannula when saturation <90%
- ❑ Caution in COPD patients: maintain an oxygen saturation between 88% and 92%
❑ Administer beta-blockers (unless contraindicated) and titrate to the heart rate and blood pressure
Contraindicated in heart failure , prolonged or high degree AV block , reactive airway disease , high risk of cardiogenic shock and low cardiac output state
- ❑ Metoprolol IV, 5 mg every 5 min, up to 3 doses, then 25 to 50 mg orally every 6 hours
- ❑ Carvedilol IV, 25 mg, two times a day
❑ Administer sublingual nitroglycerin 0.4 mg every 5 minutes for a total of 3 doses
Contraindicated in suspected right ventricular MI , recent use of phosphodiesterase inhibitors , decreased blood pressure 30 mmHg below baseline
❑ Administer IV morphine if persistent symptoms or pulmonary edema
- ❑ Initial dose 4-8 mg
- ❑ 2-8 mg every 5 to 15 minutes, as needed
❑ Administer 80 mg atorvastatin
❑ Monitor with a 12-lead ECG all the time
| | | | |
| | | | | | | | |
| | | Does the patient have any of the following indications that require immediate angiography and revascularization ?
❑ Hemodynamic instability or cardiogenic shock
❑ Severe left ventricular dysfunction or heart failure
❑ Recurrent or persistent rest angina despite intensive medical therapy
❑ New or worsening mitral regurgitation or new VSD
❑ Sustained VT or VF
❑ Prior PCI within past 6 months or CABG |
| | | | | | | | | | | | |
| | | | | | | |
YES | | | | NO | | |
| | | | | | | | | | | | | |
| | | | | | | Does the patient have negative ECG findings AND negative biomarkers? | | |
| | | | | | | | | | | | | | | |
| | | | | |
| | | | | Yes | | No |
| | | | | | | | | | | | | | |
| | | | | Repeat ECG and biomarkers within next 6 hours and 12 hours | | | | | |
| | | | | | | | | | | | | | | |
| | | | | |
| | | Both negative | | At least one positive | | |
| | | | | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | |
| | High risk Initial invasive strategy | | {{{ D03 }}} | |
| | | | | | | | | | | | | | |
Administer ONE of the following antiplatelet agents (before or at the time of PCI):
❑ P2Y12 receptor inhibitors
- ❑ Clopidogrel 600 mg
- ❑ Ticagrelor 180 mg
- ❑ Prasugrel 60 mg
Prasugrel is contraindicated in case of prior history of strokes or TIAs, active pathological bleeding, age ≥75 years, when urgent coronary artery bypass graft surgery (CABG) is likely, body weight <60 kg, propensity to bleed, concomitant use of medications that increase the risk of bleeding
❑ IV GP IIb/IIIa inhibitors
- ❑ Abciximab
- ❑ Loading dose 0.25 mg/kg IV bolus
- ❑ Maintenance dose 0.125 mg/kg/min
- ❑ Eptifibatide
- ❑ Loading dose 180 mcg/kg IV bolus
- ❑ Another 180 mcg/kg IV bolus after 10 minutes
- ❑ Maintenance dose 2 mcg/kg/min
- ❑ Decrease infusion by 50% if creatinine clearance <50 mL/min
- ❑ Avoid in hemodialysis patients
- ❑ Tirofiban
- ❑ Loading dose 25 mcg/kg
- ❑ Maintenance dose 0.15 mcg/kg/min
- ❑ Decrease infusion by 50% if creatinine clearance <30 mL/min
Administer ONE of the following anticoagulant therapy:
❑ Unfractionated heparin
- ♦ If GP IIb/IIIa receptor antagonist is planned
- ❑ 50- to 70-U/kg IV bolus
- ♦ If no GP IIb/IIIa receptor antagonist is planned
- ❑ 70- to 100-U/kg bolus
❑ Bivalirudin
- ❑ 0.75-mg/kg IV bolus, then 1.75–mg/kg/h infusion
- ❑ Additional bolus of 0.3 mg/kg if needed
- ❑ Decrease infusion to 1 mg/kg/h when creatinine clearance <30 mL/min
| | Administer one of the following antiplatelet agents:
Before PCI
❑ P2Y12 receptor inhibitors
- ❑ Clopidogrel (600 mg), or
- ❑ Ticagrelor (180 mg), or
❑ IV GP IIb/IIIa inhibitors
- ❑ Eptifibatide
- ❑ Loading dose 180 mcg/kg IV bolus followed by another bolus after 10 minutes
- ❑ Maintenance dose 2 mcg/kg/min, or
- ❑ Tirofiban
- ❑ Loading dose 25 mcg/kg
- ❑ Maintenance dose 0.15 mcg/kg/min
At the time of PCI
❑ P2Y12 receptor inhibitors
- ❑ Clopidogrel (600 mg), or
- ❑ Ticagrelor (180 mg), or
- ❑ Prasugrel (60 mg)
❑ IV GP IIb/IIIa inhibitors
- ❑ Eptifibatide
- ❑ Loading dose 180 mcg/kg IV bolus followed by another bolus after 10 minutes
- ❑ Maintenance dose 2 mcg/kg/min, or
- ❑ Tirofiban
- ❑ Loading dose 25 mcg/kg
- ❑ Maintenance dose 0.15 mcg/kg/min
| | Administer one of the following antiplatelet agents:
❑ Clopidogrel
- ❑ Loading dose (300 mg)
- ❑ Maintenance dose for up to 12 months (75 mg)
❑ Ticagrelor
- ❑ Loading dose (180 mg)
- ❑ Maintenance dose for up to 12 months (90 mg twice daily)
|
| | | | | | | | | | | | | | |
Consider urgent CABG if the coronary anatomy is not amenable to PCI and one of the following:[1] ❑ Patients with left main or left main equivalent disease ❑ Patients with three or two vessel disease involving the left anterior descending artery with left ventricular dysfunction ❑ Diabetic patients | | | | | |